The AJMC® Atopic Dermatitis compendium is a comprehensive resource for clinical news and expert insights for the chronic skin condition that typically develops in early childhood.
Develop a deeper understanding of the atopic dermatitis (AD) patient journey, explore topical therapies and treatment sequencing advancements, and gain insight regarding the payer’s perspective on AD therapies.
Dr Martin Dahl Summarizes Findings, Limitations of Study Analyzing ANB032 Use in Patients With AD
Dr Lawrence Eichenfield Hopeful for New Pediatric AD Treatment Option
Dr Lawrence Eichenfield Discusses Positive Results of Roflumilast Cream 0.05% in Pediatric Patients With AD
Dr Jonathan Silverberg Describes AD Diagnosis, Treatment in Children vs Adults
Dr Raj Chovatiya Explains Oral JAK Inhibitor Monitoring Protocols for AD Treatment
Dr Raj Chovatiya Provides Evidence Supporting Oral JAK Inhibitor Use to Treat AD
Dr Amy Paller: Safety Is of Paramount Importance When Choosing Systemic Therapies for Children With AD
Dr Amy Paller Discusses Using Systemic Therapies to Treat Children With AD
Dr Elaine Siegfried Summarizes AD Treatment Guideline Update
Dr Jonathan Silverberg Lists Which Patients With AD Benefit Most From JAK Inhibitors